Cargando…

Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients

Prognosis of metastatic neuroblastoma is very poor. Its treatment includes induction chemotherapy, surgery, high-dose chemotherapy, radiotherapy, and maintenance with retinoic acid, associated with the anti-GD2 monoclonal antibody (ch14.18) dinutuximab. Immunotherapy determined a significant improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mastrangelo, Stefano, Rivetti, Serena, Triarico, Silvia, Romano, Alberto, Attinà, Giorgio, Maurizi, Palma, Ruggiero, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657961/ https://www.ncbi.nlm.nih.gov/pubmed/34884452 http://dx.doi.org/10.3390/ijms222312648

Ejemplares similares

Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment
por: Triarico, Silvia, et al.
Publicado: (2021)

Transdermal buprenorphine for pain management in children
por: Attinà, Giorgio, et al.
Publicado: (2021)

Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors
por: Romano, Alberto, et al.
Publicado: (2022)

Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy
por: Triarico, Silvia, et al.
Publicado: (2022)

Opioid transdermal delivery system: a useful method for pain management in children
por: Mastrangelo, Stefano, et al.
Publicado: (2021)

Role of Partial Splenectomy in Hematologic Childhood Disorders
por: Attina’, Giorgio, et al.
Publicado: (2021)

Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients
por: Rivetti, Serena, et al.
Publicado: (2023)

BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
por: Talloa, Dario, et al.
Publicado: (2022)

Temozolomide and oral etoposide in children with recurrent malignant brain tumors
por: Ruggiero, Antonio, et al.
Publicado: (2020)

Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors
por: Triarico, Silvia, et al.
Publicado: (2019)

Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
por: Ruggiero, Antonio, et al.
Publicado: (2020)

Gynecological cancer among adolescents and young adults (AYA)
por: Triarico, Silvia, et al.
Publicado: (2020)

Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications
por: Capozza, Michele Antonio, et al.
Publicado: (2021)

Management of Oral Mucositis in Children With Malignant Solid Tumors
por: Attinà, Giorgio, et al.
Publicado: (2021)

Oral Microbiota during Childhood and Its Role in Chemotherapy-Induced Oral Mucositis in Children with Cancer
por: Triarico, Silvia, et al.
Publicado: (2022)

Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer
por: Romano, Alberto, et al.
Publicado: (2020)

Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors
por: Romano, Alberto, et al.
Publicado: (2023)

Dinutuximab beta for neuroblastoma
Publicado: (2020)

Multimodal treatment of pediatric patients with Askin’s tumors: our experience
por: Triarico, Silvia, et al.
Publicado: (2018)

Correction to: Multimodal treatment of pediatric patients with Askin’s tumors: our experience
por: Triarico, Silvia, et al.
Publicado: (2018)

Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine
por: Mastrangelo, Stefano, et al.
Publicado: (2022)

Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed)
por: Romano, Alberto, et al.
Publicado: (2022)

Managing children with brain tumors during the COVID-19 era: Don’t stop the care!
por: Capozza, Michele Antonio, et al.
Publicado: (2021)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma
por: Ehlert, Karoline, et al.
Publicado: (2020)

Development of a variant of dinutuximab with enhanced antitumor efficacy and reduced induction of neuropathic pain
por: Liu, Xin‐Yuan, et al.
Publicado: (2022)

Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
por: Spasov, Neofit, et al.
Publicado: (2021)

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Neuropathic pain in hereditary peripheral neuropathy
por: Jeong, Na Young, et al.
Publicado: (2013)

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
por: Keyel, Michelle E, et al.
Publicado: (2018)

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma
por: Launspach, Michael, et al.
Publicado: (2021)

Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction
por: Cupit-Link, Margaret, et al.
Publicado: (2023)

Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry
por: El Amrani, Mohsin, et al.
Publicado: (2018)

Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma
por: Balaguer, Julia, et al.
Publicado: (2022)

Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment
por: Ruggiero, Antonio, et al.
Publicado: (2018)

Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials
por: Wieczorek, Aleksandra, et al.
Publicado: (2022)

Neuropathic Pain Related to Peripheral Neuropathies According to the IASP Grading System Criteria
por: Di Stefano, Giulia, et al.
Publicado: (2020)

Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model
por: Ornell, Kimberly J., et al.
Publicado: (2020)

Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia
por: Giljević, Jasminka Stepan, et al.
Publicado: (2022)

Neonatal pharmacology and clinical implications
por: Ruggiero, Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j78ll31q13nuf2nth7lmj8f3cn